Fast blood flow protects against atherosclerosis: implications for treatment
Advertisement
The Scientist
Most Recent
The minority of Parkinson’s cases now known to have genetic origins are shedding light on the cellular mechanisms of all the rest, bringing researchers closer to a cause—and perhaps a cure.
What substance is supposed to have no effect but can make people feel better, has no chance for a big monetary payoff but is worth billions, and is used in virtually every rigorous clinical trial but has no single, universal formulation? The answer
As much as rainforests or deep-sea vents, the human gut holds rich stores of microbial chemicals that should be mined for their pharmacological potential.
The surprising results when drug development and altruism collide
A snapshot of the highest-ranked articles from a 30-day period on Faculty of 1000
Botanical Biopharming
| September 1, 2010
Green-thumbed biotechs say they can use plants to make drugs faster, cheaper, and better than top pharmaceutical companies.
Despite chill winds on Wall Street, investors continue to place bets on fledgling biotechnology companies.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
